Gland Pharma

Market Cap: Large Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE068V01023
NSEID: GLAND
BSEID: 543245

INR

1,401.40

8.15 (0.58%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 6.11 lacs

{
  "main_header": {
    "sid": 1003443,
    "name": "Gland Pharma",
    "stock_name": "Gland Pharma",
    "full_name": "Gland Pharma Ltd",
    "name_url": "stocks-analysis/gland-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,401.40",
    "chg": 8.15,
    "chgp": "0.58%",
    "dir": 1,
    "prev_price": "1,393.25",
    "mcapval": "23,088.97 Cr",
    "mcap": "Large Cap",
    "scripcode": 543245,
    "symbol": "GLAND",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE068V01023",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "01:24 AM",
    "bse_nse_vol": "6.11 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gland-pharma-1003443-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Gland Pharma Shows Trend Reversal Amid Mixed Long-Term Performance in Pharmaceuticals Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-stock-rises-7-58-amid-broader-market-decline-on-april-3-2025-1693579",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/GlandPharma_priceRelatedfactors_883385.png",
        "date": "2025-04-03 09:35:30",
        "description": "Gland Pharma experienced a notable rebound on April 3, 2025, reversing two days of decline with a significant intraday gain. The stock has outperformed its sector recently, despite longer-term challenges. Its moving averages indicate a mixed performance relative to various timeframes within the pharmaceuticals industry."
      },
      {
        "title": "Gland Pharma Faces Mixed Technical Signals Amidst Market Volatility and Declining Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharmas-technical-trend-changes-from-mildly-bearish-to-bearish-amid-stock-decline-1670841",
        "imagepath": "",
        "date": "2025-04-02 08:09:42",
        "description": "Gland Pharma, a prominent player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 1555.05, down from a previous close of 1610.00, with a notable 52-week high of 2,220.95 and a low of 1,412.00. Today's trading saw a high of 1607.35 and a low of 1549.60, indicating some volatility.\n\nThe technical summary for Gland Pharma reveals mixed signals across various indicators. The MACD shows a mildly bullish trend on a weekly basis but shifts to mildly bearish on a monthly scale. The Relative Strength Index (RSI) indicates no significant signals for both weekly and monthly periods. Bollinger Bands and Moving Averages suggest bearish tendencies, while the KST presents a bearish outlook weekly and mildly bearish monthly.\n\nIn terms of performance, Gland Pharma's returns have lagged behind the Sensex across multip..."
      },
      {
        "title": "Gland Pharma Faces Significant Challenges Amid Broader Market Trends and Declining Stock Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-stock-declines-3-02-amid-broader-market-downturn-on-april-1-2025-1660962",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/GlandPharma_priceRelatedfactors_853201.png",
        "date": "2025-04-01 11:50:27",
        "description": "Gland Pharma has faced challenges in its stock performance, experiencing a decline on April 1, 2025, that contrasts with broader market trends. While the stock is above its 50-day moving average, it has shown a notable decrease over the past three months and year, diverging from the Sensex's gains."
      },
      {
        "title": "Gland Pharma Opens Strong with 4.53% Gain, Outperforming Sector and Sensex",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-stock-opens-4-53-higher-outperforming-sector-by-2-82-1574183",
        "imagepath": "",
        "date": "2025-03-24 10:40:17",
        "description": "Gland Pharma, a prominent player in the Pharmaceuticals & Drugs industry, has shown significant activity today, opening with a gain of 4.53%. The stock reached an intraday high of Rs 1664.4, reflecting a 5.82% increase at its peak. In terms of performance metrics, Gland Pharma outperformed its sector by 2.82%, with a one-day performance of 3.58% compared to the Sensex's 0.99%. Over the past month, Gland Pharma has achieved a 7.06% increase, while the Sensex has risen by 4.31%.\n\nAnalyzing the technical indicators, Gland Pharma's moving averages are currently higher than the 5-day, 20-day, and 50-day averages, but lower than the 100-day and 200-day averages. The MACD indicates a bearish trend on a weekly basis, while showing a mildly bullish stance monthly. The Bollinger Bands and KST also reflect a mildly bearish outlook on both weekly and monthly charts. Overall, Gland Pharma's stock activity today highligh..."
      },
      {
        "title": "Gland Pharma Experiences Short-Term Recovery Amid Long-Term Underperformance Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-stock-rises-3-51-amid-broader-market-gains-and-sell-call-issued-1573311",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/GlandPharma_priceRelatedfactors_771115.png",
        "date": "2025-03-24 09:35:35",
        "description": "Gland Pharma experienced significant activity on March 24, 2025, with a notable intraday high and outperforming its sector. While the stock has shown short-term recovery, it faces challenges with declines over the past three months and year, indicating complexities within the pharmaceutical market."
      },
      {
        "title": "Gland Pharma Experiences Increased Volatility Amid Positive Short-Term Performance Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-gains-3-32-amid-broader-market-recovery-on-march-21-2025-1555488",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/GlandPharma_priceRelatedfactors_768842.png",
        "date": "2025-03-21 15:35:30",
        "description": "Gland Pharma has demonstrated significant activity, gaining 3.32% on March 21, 2025, and outperforming its sector. The stock reached an intraday high of Rs 1680, with notable volatility. While it has shown positive returns over the past week, its three-month and year-to-date performance reflects declines."
      },
      {
        "title": "Gland Pharma Faces Mixed Technical Trends Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharmas-technical-trend-shifts-from-bearish-to-mildly-bearish-amid-stock-price-increase-5-1451236",
        "imagepath": "",
        "date": "2025-03-19 08:05:03",
        "description": "Gland Pharma, a prominent player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 1581.25, showing a notable change from the previous close of 1548.60. Over the past year, Gland Pharma has faced challenges, with a return of -11.61%, contrasting with a positive return of 3.51% for the Sensex during the same period.\n\nThe technical summary indicates a mixed performance across various indicators. The MACD shows a bearish trend on a weekly basis, while the monthly perspective leans mildly bullish. The Relative Strength Index (RSI) presents no clear signals, and Bollinger Bands are categorized as mildly bearish for both weekly and monthly assessments. Moving averages also reflect a mildly bearish stance on a daily basis, while the KST indicates a bearish trend weekly and mildly bearish monthly.\n\nIn terms o..."
      },
      {
        "title": "Gland Pharma Experiences Valuation Grade Change Amidst Competitive Pharmaceutical Landscape",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharmas-valuation-grade-changes-from-expensive-to-fair-amid-stock-price-decline-1397406",
        "imagepath": "",
        "date": "2025-03-17 08:01:01",
        "description": "Gland Pharma, a prominent player in the Pharmaceuticals & Drugs sector, has recently undergone a valuation adjustment. The company's current price stands at 1554.15, reflecting a decline from its previous close of 1581.95. Over the past year, Gland Pharma has experienced a stock return of -8.07%, contrasting with a modest gain of 1.47% in the Sensex.\n\nKey financial metrics for Gland Pharma include a PE ratio of 36.35 and an EV to EBITDA ratio of 18.06, indicating its market positioning within the industry. The company's return on capital employed (ROCE) is reported at 14.18%, while the return on equity (ROE) is at 7.87%. \n\nIn comparison to its peers, Gland Pharma's valuation metrics present a mixed picture. For instance, Sun Pharma is noted for its higher PE ratio of 34.25, while Divi's Laboratories stands out with a significantly elevated PEG ratio of 72.07. Other competitors like Cipla and Dr. Reddy's Lab..."
      },
      {
        "title": "Gland Pharma Experiences Technical Trend Adjustments Amid Mixed Performance Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharmas-technical-trend-shifts-from-mildly-bearish-to-bearish-amid-stock-decline-12-1371751",
        "imagepath": "",
        "date": "2025-03-13 08:02:44",
        "description": "Gland Pharma, a prominent player in the Pharmaceuticals & Drugs sector, has recently undergone a technical trend adjustment. The company's current stock price stands at 1581.95, reflecting a slight decline from the previous close of 1605.00. Over the past year, Gland Pharma has experienced a stock return of -8.73%, contrasting with a modest gain of 0.49% in the Sensex during the same period.\n\nIn terms of technical indicators, the weekly MACD and Bollinger Bands signal bearish trends, while the monthly MACD shows a mildly bullish stance. The Relative Strength Index (RSI) currently indicates no signal for both weekly and monthly assessments. Moving averages also reflect a bearish sentiment on a daily basis, with the KST and Dow Theory showing bearish and mildly bearish trends, respectively.\n\nGland Pharma's performance over various time frames reveals a mixed picture. In the last month, the stock returned 7.9%..."
      }
    ],
    "total": 111,
    "sid": "1003443",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/gland-pharma-1003443"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "03-Apr-2025",
      "details": "Gland Pharma receives approval for Acetaminophen Injection",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
      "datetime": "31-Mar-2025",
      "details": "Postal Ballot Voting Results",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "31-Mar-2025",
      "details": "Postal Ballot Results - Scrutinizer Report",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Gland Pharma Ltd has declared <strong>2000%</strong> dividend, ex-date: 16 Aug 24",
          "dt": "2024-08-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Gland Pharma Shows Trend Reversal Amid Mixed Long-Term Performance in Pharmaceuticals Sector

2025-04-03 09:35:30

Gland Pharma experienced a notable rebound on April 3, 2025, reversing two days of decline with a significant intraday gain. The stock has outperformed its sector recently, despite longer-term challenges. Its moving averages indicate a mixed performance relative to various timeframes within the pharmaceuticals industry.

Gland Pharma Faces Mixed Technical Signals Amidst Market Volatility and Declining Performance

2025-04-02 08:09:42

Gland Pharma, a prominent player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 1555.05, down from a previous close of 1610.00, with a notable 52-week high of 2,220.95 and a low of 1,412.00. Today's trading saw a high of 1607.35 and a low of 1549.60, indicating some volatility. The technical summary for Gland Pharma reveals mixed signals across various indicators. The MACD shows a mildly bullish trend on a weekly basis but shifts to mildly bearish on a monthly scale. The Relative Strength Index (RSI) indicates no significant signals for both weekly and monthly periods. Bollinger Bands and Moving Averages suggest bearish tendencies, while the KST presents a bearish outlook weekly and mildly bearish monthly. In terms of performance, Gland Pharma's returns have lagged behind the Sensex across multip...

Gland Pharma Faces Significant Challenges Amid Broader Market Trends and Declining Stock Performance

2025-04-01 11:50:27

Gland Pharma has faced challenges in its stock performance, experiencing a decline on April 1, 2025, that contrasts with broader market trends. While the stock is above its 50-day moving average, it has shown a notable decrease over the past three months and year, diverging from the Sensex's gains.

Gland Pharma Opens Strong with 4.53% Gain, Outperforming Sector and Sensex

2025-03-24 10:40:17

Gland Pharma, a prominent player in the Pharmaceuticals & Drugs industry, has shown significant activity today, opening with a gain of 4.53%. The stock reached an intraday high of Rs 1664.4, reflecting a 5.82% increase at its peak. In terms of performance metrics, Gland Pharma outperformed its sector by 2.82%, with a one-day performance of 3.58% compared to the Sensex's 0.99%. Over the past month, Gland Pharma has achieved a 7.06% increase, while the Sensex has risen by 4.31%. Analyzing the technical indicators, Gland Pharma's moving averages are currently higher than the 5-day, 20-day, and 50-day averages, but lower than the 100-day and 200-day averages. The MACD indicates a bearish trend on a weekly basis, while showing a mildly bullish stance monthly. The Bollinger Bands and KST also reflect a mildly bearish outlook on both weekly and monthly charts. Overall, Gland Pharma's stock activity today highligh...

Gland Pharma Experiences Short-Term Recovery Amid Long-Term Underperformance Challenges

2025-03-24 09:35:35

Gland Pharma experienced significant activity on March 24, 2025, with a notable intraday high and outperforming its sector. While the stock has shown short-term recovery, it faces challenges with declines over the past three months and year, indicating complexities within the pharmaceutical market.

Gland Pharma Experiences Increased Volatility Amid Positive Short-Term Performance Trends

2025-03-21 15:35:30

Gland Pharma has demonstrated significant activity, gaining 3.32% on March 21, 2025, and outperforming its sector. The stock reached an intraday high of Rs 1680, with notable volatility. While it has shown positive returns over the past week, its three-month and year-to-date performance reflects declines.

Gland Pharma Faces Mixed Technical Trends Amid Market Evaluation Revision

2025-03-19 08:05:03

Gland Pharma, a prominent player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 1581.25, showing a notable change from the previous close of 1548.60. Over the past year, Gland Pharma has faced challenges, with a return of -11.61%, contrasting with a positive return of 3.51% for the Sensex during the same period. The technical summary indicates a mixed performance across various indicators. The MACD shows a bearish trend on a weekly basis, while the monthly perspective leans mildly bullish. The Relative Strength Index (RSI) presents no clear signals, and Bollinger Bands are categorized as mildly bearish for both weekly and monthly assessments. Moving averages also reflect a mildly bearish stance on a daily basis, while the KST indicates a bearish trend weekly and mildly bearish monthly. In terms o...

Gland Pharma Experiences Valuation Grade Change Amidst Competitive Pharmaceutical Landscape

2025-03-17 08:01:01

Gland Pharma, a prominent player in the Pharmaceuticals & Drugs sector, has recently undergone a valuation adjustment. The company's current price stands at 1554.15, reflecting a decline from its previous close of 1581.95. Over the past year, Gland Pharma has experienced a stock return of -8.07%, contrasting with a modest gain of 1.47% in the Sensex. Key financial metrics for Gland Pharma include a PE ratio of 36.35 and an EV to EBITDA ratio of 18.06, indicating its market positioning within the industry. The company's return on capital employed (ROCE) is reported at 14.18%, while the return on equity (ROE) is at 7.87%. In comparison to its peers, Gland Pharma's valuation metrics present a mixed picture. For instance, Sun Pharma is noted for its higher PE ratio of 34.25, while Divi's Laboratories stands out with a significantly elevated PEG ratio of 72.07. Other competitors like Cipla and Dr. Reddy's Lab...

Gland Pharma Experiences Technical Trend Adjustments Amid Mixed Performance Indicators

2025-03-13 08:02:44

Gland Pharma, a prominent player in the Pharmaceuticals & Drugs sector, has recently undergone a technical trend adjustment. The company's current stock price stands at 1581.95, reflecting a slight decline from the previous close of 1605.00. Over the past year, Gland Pharma has experienced a stock return of -8.73%, contrasting with a modest gain of 0.49% in the Sensex during the same period. In terms of technical indicators, the weekly MACD and Bollinger Bands signal bearish trends, while the monthly MACD shows a mildly bullish stance. The Relative Strength Index (RSI) currently indicates no signal for both weekly and monthly assessments. Moving averages also reflect a bearish sentiment on a daily basis, with the KST and Dow Theory showing bearish and mildly bearish trends, respectively. Gland Pharma's performance over various time frames reveals a mixed picture. In the last month, the stock returned 7.9%...

View All News